FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Aspirin topics
Acetylsalicylic Acid
Cardiovascular Disease
Cardiovascular
Vascular Disease
Calcium Carbonate
Nitroglycerin
Epinephrine
Eicosapentaenoic Acid
Docosahexaenoic Acid
Polyunsaturated Fatty Acid
Fondaparinux
Bivalirudin
Paclitaxel
Salicylic Acid
Vascular Diseases

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Aspirin patents



      
           
This page is updated frequently with new Aspirin-related patent applications. Subscribe to the Aspirin RSS feed to automatically get the update: related Aspirin RSS feeds. RSS updates for this page: Aspirin RSS RSS


Date/App# patent app List of recent Aspirin-related patents
09/04/14
20140248352
 Chewable enteric coated aspirin tablets patent thumbnailChewable enteric coated aspirin tablets
The invention relates to a tablet capable of being chewed or disintegrated in the oral cavity, which comprises an enteric coated aspirin active ingredient, and preferably a lightly compressed matrix comprising directly compressible carbohydrate(s) and at least one sweetener.. .
08/07/14
20140220694
 Methods and compositions relating to platelet sensitivity patent thumbnailMethods and compositions relating to platelet sensitivity
The invention identifies and describes proteins that are differentially expressed in platelets resistant to anti-platelet agents such as aspirin (acetylsalicyclic acid) compared to those platelets that are sensitive to such agents. Methods for determining further such differentially expressed proteins and methods for determining an individual's sensitivity to anti-platelet agents, such as aspirin, prior to administration..
06/26/14
20140179630
 Use of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma patent thumbnailUse of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (pufa) such as eicosapentaenoic acid (epa) or docosahexaenoic acid (dha), cyclooxygenase-ii (cox-2) and an analgesic, such as aspirin (asa). Surprisingly, careful isolation of compounds generated from the combination of components in an appropriate environment provide di- and tri-hydroxy epa or dha compounds having unique structural and physiological properties.
04/03/14
20140094519
 Lipoxin analogs as novel inhibitors of angiogenesis patent thumbnailLipoxin analogs as novel inhibitors of angiogenesis
The present invention is generally drawn to novel isolated therapeutic agents, termed lipoxins, generated from the interaction between a dietary omega-6 polyunsaturated fatty acid (pufa) such as arachidonic acid (aa), oxygenases and the analgesic aspirin (asa). Surprisingly, careful isolation of compounds generated from the combination of components in an appropriate environment provide di- and tri-hydroxy containing derivatives of aa containing compounds having unique structural and physiological properties.
03/06/14
20140066413
 Analgesic composition and method of making the same patent thumbnailAnalgesic composition and method of making the same
A soluble aspirin composition, comprising: (i) granules including aspirin, heat-treated bicarbonate salt, pharmaceutically-acceptable resin and surfactant, in mixture with: (ii) crystalline particles of pharmaceutically-acceptable acid; and (iii) crystalline particles of heat-treated bicarbonate salt; wherein the soluble aspirin composition when introduced to water undergoes reaction of the crystalline particles of pharmaceutically-acceptable acid with the heat-treated bicarbonate salt and the aspirin to effect effervescing action and disintegration of the granules with conversion of the aspirin to an acetylsalicylate compound of the bicarbonate salt cation so that the composition rapidly dissolves in the water without occurrence of undissolved residue. The composition is solubilizable within 30 seconds in cool to cold water to provide an effervescent analgesic solution that can be readily orally administered to an individual in need of analgesia..
01/23/14
20140024681
 Compounds with super-aspirin effects patent thumbnailCompounds with super-aspirin effects
A compound having the structural formula (i) and pharmaceutically acceptable salt and/or hydrates thereof, (i) wherein y is an arylester or an c1-c8 alkylaryl ester, selected from the group consisting of: benzene, toluene, xylene, benzoic acid, benzoate, nicotinate, isonicotinate and halobenzene, which can be unsubstituted or substituted with at least one nitric oxide releasing group; and/or at least one of hydroxide, —cl, —br, a c1-c8 alkyl, benzyl, a c1-c8 alkoxy, benzyloxy, —nhc(o)r, —nh2, —no2—ono2, —(ch2)nono2, —oc(o)[(ch2)n]cyclicono2, —ocoarono2, —ocoar(ch2)nono2 or a c1-c5 haloalkyl ester, wherein r is a c1-c8 alkyl or a c1-c8 alkoxy group, n=1-8 and m=3-10, to produce a super-aspirin effect.. .
12/19/13
20130338120
 Aspirin derivatives and uses thereof patent thumbnailAspirin derivatives and uses thereof
The present invention provides novel aspirin derivatives useful for preventing and/or treating cancer. The novel compounds of this invention may be particularly useful for the prevention and/or treatment of cancers affecting the gastrointestinal system, such as colorectal cancer..
09/19/13
20130243872
 Pharmaceutical composite formulation comprising hmg-coa reductase inhibitor and aspirin patent thumbnailPharmaceutical composite formulation comprising hmg-coa reductase inhibitor and aspirin
Provided is a pharmaceutical composite formulation for preventing or treating cardiovascular diseases, which comprises (1) a first particle comprising an hmg-coa reductase inhibitor and a basic additive; and (2) a second particle comprising a core containing aspirin and an enteric coating layer coated on said core, wherein the difference in the average diameters of said first and second particles is 100 μm to 800 μm; a method for preparing same; and a method of validating the quality of same. The pharmaceutical composite formulation according to the present invention can improve the stability of an active ingredient and prevent adverse impacts between the active ingredients to thereby enable an accurate quality validation of the pharmaceutical composite formulation..
09/19/13
20130243859
 Orally disintegrating tablet patent thumbnailOrally disintegrating tablet
The present invention relates to a multi-layer orally disintegrating tablet having (1) an enteric fine granule-containing layer containing a proton pump inhibitor and (2) an acetylsalicylic acid-containing layer, which shows high stability of the active ingredients (proton pump inhibitor, aspirin) and expresses the pharmacological effects of the active ingredients stably and rapidly after administration.. .
08/22/13
20130217771
 Resolvins: bioemplates for novel therapeutic interventions patent thumbnailResolvins: bioemplates for novel therapeutic interventions
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (pufa) such as eicosapentaenoic acid (epa) or docosahexaenoic acid (dha), cyclooxygenase-ii (cox-2) and an analgesic, such as aspirin (asa). Surprisingly, careful isolation of compounds generated from the combination of components in an appropriate environment provide di- and tri-hydroxy epa or dha compounds having unique structural and physiological properties.
08/15/13
20130209441
Process for inhibition of cerebral damage associated with ischemia by anthocyanins and anthocyanidins
A composition is also provided that includes ananthocyanin compound to cause blood clot dissolution. The agent being in specific embodiments is tissue plasminogen activator or aspirin..
07/25/13
20130186779
Blister pack for a container
The present invention relates to a blister pack sealed to the neck of a container and adapted to fit under the container lid forming a seal, said blister pack containing a liquid soluble material such as dissolvable aspirin. When force is applied to the blister pack, the base, which is comprised of a rupturable material, breaks and allows the liquid soluble material to be mixed with the liquid in the container.
05/16/13
20130122098
Method and composition to improve absorption of therapeutic agents
A tablet with an enhanced dissolution profile for a medicinally active ingredient such as aspirin and methods for making the tablet. The tablet comprises a blend of crystals of the medicinally active ingredient and a dissolution aid such as sodium or calcium carbonate or bicarbonate that coats the crystals upon co-milling.
05/09/13
20130115289
Anti-flush compositions
Disclosed are pharmaceutical compositions having a portion of aspirin for intraoral release and another aspirin for gastrointestinal release. The compositions can further include niacin.
02/14/13
20130040898
Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof
The present invention relates to compounds for treatment that protects the endothelium, prevents pathologic thrombus formation in the microcirculation and preserves platelet number and function and thus may be related to treatment or prevention of ischemic events in patients with cardiovascular disease. The present invention is particularly useful for patients having or being at increased risk of development of an ischemic event such as an acute myocardial infarction and/or no-reflow phenomena and/or ischemia-reperfusion injury by administration of agent(s) modulating and/or preserving endothelial integrity.
02/07/13
20130035317
Di-aspirin derivatives
The invention relates to the use of di-aspirin (bis(2-carboxyphenyl)succinate) and its derivatives in the treatment of colon and colorectal cancer. It also relates to novel derivatives of di-aspirin and to a method of synthesis of the di-aspirin and its derivatives..
01/31/13
20130029922
Formulations from natural products, turmeric, paclitaxel, and aspirin
The invention provides novel compounds and formulations of turmeric oil, fish oil, aspirin and anti-cancer drugs (paclitaxel) having anti-inflammatory, analgesic and/or anti-cancer activity.. .


Popular terms: [SEARCH]

Aspirin topics: Acetylsalicylic Acid, Cardiovascular Disease, Cardiovascular, Vascular Disease, Calcium Carbonate, Nitroglycerin, Epinephrine, Eicosapentaenoic Acid, Docosahexaenoic Acid, Polyunsaturated Fatty Acid, Fondaparinux, Bivalirudin, Paclitaxel, Salicylic Acid, Vascular Diseases

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Aspirin for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Aspirin with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.1803

728

1 - 1 - 17